The present invention relates to a method for the diagnosis and/or prognosis of a neurological disease characterized by an inflammatory process as well as a method for predicting and /or monitoring the efficacy of a treatment for a neurological pathology. The methods are based on the measurement of the amount of myeloid derived microvesicles in a cerebrospinal fluid sample.
|Titolo:||Increase of myeloid microvesicles in the cerebrospinal fluid as biomarkers of microglia/microphage activation in neurological disorders|
|Data di pubblicazione:||2011|
|Appare nelle tipologie:||6.1 Brevetto|